Liu Xiaoli Jacqueline 4
4 · Evelo Biosciences, Inc. · Filed Jul 14, 2020
Insider Transaction Report
Form 4
Liu Xiaoli Jacqueline
Principal Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-07-10+30,000→ 30,000 totalExercise: $4.20Exp: 2030-07-10→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option vests as to 75% of the shares (22,500) on July 10, 2022 and as to 25% of the shares (7,500) on July 10, 2023.